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Abstract: Background: Ketogenic diet (KD) is a nutritional approach that restricts daily carbohy-
drates, replacing most of the reduced energy with fat, while maintaining an adequate quantity of
protein. Despite the widespread use of KD in weight loss in athletes, there are still many concerns
about its use in sports requiring muscle mass accrual. Thus, the present study sought to investi-
gate the influence of a KD in competitive natural body builders. Methods: Nineteen volunteers
(27.4 ± 10.5 years) were randomly assigned to ketogenic diet (KD) or to a western diet (WD). Body
composition, muscle strength and basal metabolic rate were measured before and after two months
of intervention. Standard blood biochemistry, testosterone, IGF-1, brain-derived neurotrophic factor
(BDNF) and inflammatory cytokines (IL6, IL1β, TNFα) were also measured. Results: Body fat signif-
icantly decreased in KD (p = 0.030); whilst lean mass increased significantly only in WD (p < 0.001).
Maximal strength increased similarly in both groups. KD showed a significant decrease of blood
triglycerides (p < 0.001), glucose (p = 0.001), insulin (p < 0.001) and inflammatory cytokines compared
to WD whilst BDNF increased in both groups with significant greater changes in KD (p < 0.001).
Conclusions: KD may be used during body building preparation for health and leaning purposes
but with the caution that hypertrophic muscle response could be blunted.
Keywords: ketogenic diet; strength; resistance training; health
1. Introduction
Ketogenic diet (KD) is a nutritional approach based on a reduced intake of carbohy-
drates (less than 20/30 g per day or 5% of total energy) [1–3], a high fat content and an
adequate level of proteins, the latter generally close to or slightly higher than the Italian
recommended daily intake (LARNs recommendation) of 0.9 g per kg of body weight [4].
The metabolic advantage induced by KD is represented by the drastic reduction in carbo-
hydrates, which force the body to primarily use fat as a fuel source as demonstrated by the
decrease of the respiratory exchange ratio (RER) [5,6].
Glucose is a fundamental energy source for the central nervous system, which is
protected by the blood-brain barrier not allowing the passage of free fatty acids. After
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a few days of KD, there is a drop in glucose availability due to reduced glycogen stores
and thus an alternative energy source is required [7,8]. This energy is supplied by ketone
bodies (KBs): acetoacetate (AcAc), 3-hydroxybutyrate (BHB) and acetone. KBs are gen-
erated through a process called ketogenesis from acetyl-CoA that occurs mainly in the
mitochondrial matrix of the liver. Although created in the liver, this organ is unable to
utilize KB due to a lack of the succinyl-CoA: 3-CoA transferase enzyme, which is required
to convert acetoacetate to aceto-acetyl-CoA. KBs are thus released into the extrahepatic
bloodstream and can be used by other tissues as energy source, by converting BHB into
acetoacetate and then into aceto-acetyl-CoA, which can be further transformed into two
acetyl-CoA molecules and enter the Krebs cycle [9]. At the end of this process, the energy
produced from KBs is greater compared with glucose [2,10]. Initially, the necessary amount
of acetyl-CoA is supplied by hepatic glycogenolysis and gluconeogenesis, but after four–
seven days of KD, lipolysis of adipose tissue becomes the main source. In the long term,
this adaptation translates into a reduction in the respiratory ratio which represents the
metabolic switch towards a greater reliance on fatty acids [6,11].
KD is a well-proven approach to promote weight loss [2], and it has recently been used
as a valuable therapeutic option to treat metabolic disorders, cardiovascular disease and
type 2 diabetes [12]. Its role in sport performance is still controversial, with some authors
experiencing favorable effects [3,13] whilst other discourage the use of such dietetic ap-
proach, at least in endurance sports [14–16]. For athletes who compete in weight-category
sports, KD could be a safe weight loss method, not compromising performance, therefore it
may represent a legitimate and important tool for athletes. Paoli et al., for instance, demon-
strated that 30 days of KD decreased body weight and body fat without negative effects
on strength in high level gymnasts [13]. However, it might seem counterproductive for
those athletes who seek maximum muscle hypertrophy [17], as several studies have shown
no accretion of muscle mass during the ketosis phase [13,18–20]. Despite this, numerous
bodybuilders use KD without a justified reason; however, no studies have yet explored its
role in this particular sport category [21–23]. Professional bodybuilders’ goals are to keep
a perfect balance between muscle size and body fat, in order to obtain the most accurate
symmetry and muscular proportion. To achieve their objectives, bodybuilders undergo a
cycle of different training intensities in combination with various dietetic regimen in order
to increase muscle mass during the “off-season” and reduce fat mass during competition
preparation [21]. In this context, KD seems to be a useful diet to reduce fat mass, but its
role in preserving athletic performance and muscle hypertrophy in physique athletes is
still poorly investigated.
The high intensity and frequency of training employed by bodybuilders during their
contest preparation may also induce muscle damage [24–26], which could ultimately result
in a chronic inflammatory status, with increased level of IL-6, IL-1 and TNF-α [27]. On
the other hand, a weight loss program can increase stress, anxiety and negatively affect
athlete’s mood [28]. The brain-derived neurotrophic factor (BDNF) is a protein associated
with major depressive disorders and stress situations [29,30]. It has been shown that
KD may have positive effects on inflammation [31–33] and can reduce depression-like
behaviors [34] in both animals and human models, but no data are available about its effect
on athletes such as bodybuilders.
The aim of the present study is to evaluate the effects of the ketogenic diet on body
composition, muscle mass, strength and some blood parameters mainly related to lipid
profile, hormonal (i.e., IGF-1) and inflammatory status (i.e., IL-6, TNFα and IL-1β) in
competitive body building athletes. Basal metabolism and respiratory quotient were also
assessed in order to monitor the metabolic adaptation to KD.
2. Materials and Methods
This study is a randomized controlled parallel study (Figure 1). After signing the
informed consent, the participants were invited to refer to the Exercise Nutrition and
Physiology laboratory of the Department of Biomedical Sciences of the University of
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Padova. During the first visit, the participants underwent a medical screening to ensure
eligibility for the study and a food interview to gather information on the participants’
dietary habits. Subjects were examined after overnight fasting for blood sample collection,
followed by body composition measurements via bioimpedance analysis (BIA) and basal
metabolic rate assessment via indirect calorimetry. In a second visit, participants underwent
maximal strength tests (1-RM) for bench press and squat exercises. During the second visit,
all subjects received a personalized diet protocol, to be followed for eight weeks; adherence
to the dietary regimen and ketonemia were monitored weekly through a portable device.
Weekly results of blood BHB were sent to the research team: a value under 0.5 mmol/L
was selected as non-adherence index and used to exclude subjects from the analysis. All
participants maintained BHB levels over the defined limit and were included in the final
analysis. Participants kept their own training routine, which was personalized and different
for all participants. Athletes took part in the study in a period away from the competition
phase: workouts had a daily schedule and were divided by muscle groups, and training
sessions included exercises mainly aimed at increasing strength and muscle mass. After
eight weeks subjects repeated the strength tests and body composition analysis and basal
metabolism were reassessed 72 h after the last workout blood sampling
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included in the study if they had at least five years of training experience and were com-
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chronic use of any medication, metabolic disorders or any other clinical problems that 
could be aggravated by the study procedures. Use of steroids was excluded by coaches’ 
interview, and as athletes had officially enrolled in natural body building categories. Table 
1 shows the anthropometric characteristics at baseline. Before any procedures, all partici-
pants signed the informed consent for data collection approved by the ethical committee 
of the Department of Biomedical Sciences, University of Padova (HEC-DSB 11/19), accord-
ing to the current Declaration of Helsinki. At the end of the first screening, subjects were 
randomly assigned to these experimental groups: ketogenic diet (KD; n = 9) or control 
western diet (WD; n = 10). The study was retrospectively registered at clinical trials.gov 
as NCT04629365. 
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2.1. Subjects
ineteen male athletes (age 27.42 ± 10.54 years; BMI 26.80 ± 1.91 kg/ 2; lean mass
88.62 2.81 ) ere recr ite fr t e s rts centers of E ilia-Ro ag a and Veneto
through advertising direct to coaches. Subjects aged bet een 20 and 40 years old were
included in the study if they had at least five years of training experience and were
competing in a recognized body building category. Exclusion criteria ere use of steroids,
chronic use of any medication, metabolic disorders or any other clinical problems that could
be aggravated by the study procedures. Use of steroids was excluded by coaches’ interview,
and as athletes had officially enrolled in natural body building categories. Table 1 shows
the anthropometric characteristics at baseline. Before any procedures, all participants
signed the informed consent for data collection approved by the ethical committee of the
Department of Biomedical Sciences, University of Padova (HEC-DSB 11/19), according
to the current Declaration of Helsinki. At the end of the first screening, subjects were
randomly assigned to these experimental groups: ketogenic diet (KD; n = 9) or control
western diet (WD; n = 10). The study was retrospectively registered at clinical trials.gov as
NCT04629365.
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Table 1. Baseline characteristics of Ketogenic Diet (KD) and control western diet (WD) groups.
KD (n = 9) WD (n = 10) p-Value
Age (y) 26.22 ± 5.09 31.67 ± 10.39 0.16
Weight (kg) 86.39 ± 15.42 89.04 ± 11.73 0.68
BMI (kg/m2) 26.97 ± 1.86 26.66 ± 2.04 0.73
Lean mass (%) 88.88 ± 2.66 88.38 ± 3.06 0.71
All values are means ± SD. KD, ketogenic diet group; WD, western diet group.
2.2. Measurements
Subjects underwent blood sampling after an overnight fast for blood glucose, insulin,
total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, aspartate transaminase
(AST), alanine amino transferase (ALT), total testosterone, insulin growth factor 1 (IGF-
1), brain-derived neurotrophic factor (BDNF), interleukin-1 (IL-1); interleukin-6 (IL-6)
and tumor growth factor (TNF-α). All the analysis was performed by an accredited and
certified laboratory.
Body composition assessment was performed by Bioelectrical Impendence Analysis
(Akern mod. STA/BIA 101/S, Pontassieve, FI, Italy). Subjects were asked to lie down
and rest for about three–five min in order to allow a balanced redistribution of body
fluids. Four skin electrodes were then applied, one on the back of the hand, one on the
metacarpal-phalangeal joint of the third finger, one on the dorsum of the ipsilateral foot
at the metatarsal-phalangeal joint of the third finger and one on the ankle joint. Using
dedicated analysis software (Akern, Body Pro, Pontassieve, Italy) we obtained the values
of lean mass (FFM) and fat mass (FM).
Basal metabolism (REE) and respiratory quotient (RER) were measured via indirect
calorimetry. Before each procedure, the respiratory gas analyzer (Max Encore 29 System,
Vmax, Viasys Healthcare, Inc., Yorba Linda, CA, USA) was calibrated using a special
syringe. During the test, participants lay on a cot in a room that was not too bright,
quiet and with a temperature of about 24 ◦C. During the test, participants were asked to
breathe regularly in a silicone mask that allowed the analysis of respiratory gases. Data
was collected for 30 min, however, only the last 20 min were taken into account for data
analysis. REE was calculated starting from oxygen consumption (VO2), based on the Weir
equation, while RER was derived from the ratio between the production of VO2 and carbon
dioxide (VCO2).
Muscle strength was assessed during the second visit. 1-RM test was performed
during the squat exercise for the lower limbs’ strength, and during the bench press exercise,
for the pectorals as previously described [35].
Subjects were requested to refrain from any physical exercise other than normal
activities of daily living for at least 48 h prior to testing. Repetition maximum testing
was performed according to the guidelines of the National Strength and Conditioning
Association [36]. Briefly, subjects performed a general warm-up prior to testing, followed
by a specific warm-up set for each exercise consisting of 5 repetitions at 50% of an estimated
1-RM followed by one to two sets of 2–3 repetitions at a load corresponding to 60–80%
of 1-RM. Subjects were then asked to gradually reach the load with which they could
perform a maximum of one repetition while maintaining the correct realization of the
movement: for the bench press the barbell had to touch the chest and return to full arm
extension at each repetition without bouncing, and during the squat each movement had
to be completed with thighs parallel to the floor
2.3. Diet Protocols
The diet was formulated by a dietary team on the basis of the food interview that took
place during the first screening visit and in consideration of the specific caloric energy and
macronutrient needs for body-building athletes [37] using software for the elaboration of
diets (Dieta Ragionata 7.0).
Nutrients 2021, 13, 374 5 of 14
The two diet regimens were isocaloric and included the same amount of protein per
kg of body weight. The caloric intake of the dietary patterns provided was calculated by
assigning an energy expenditure of 45 kcal/kg of muscle mass, while the protein intake
was maintained at 2.5 g/kg/body weight as suggested by Apong in 2019 [37]. The two
protocols differed in the distribution of fats and carbohydrates; the latter were kept below
5% daily (less than 50 g/day) in the KD group while they represented 55% of the caloric
intake in the WD group. The caloric and macronutrient distribution are shown in Table 2.
Bodybuilders are known to slavishly follow prescribed diets, normally composed of a
restricted and repetitive food regimen [23,38,39]. This condition helped to guarantee the
adherence to the prescribed diet in both groups throughout the study. Moreover, blood
BHB was regularly checked to avoid exit from ketosis in the KD group.
Table 2. Diet composition and macronutrients distribution.
KD (n = 9) WD (n = 10)
Total Energy intake (kcal/day) 3443.70 ± 545.94 3529.71 ± 374.06
Protein (kcal) 863.89 ± 154.19 890.40 ± 117.30
Carbohydrates (kcal) 175.00 ± 28.17 1952.50 ± 209.43 *
Fat (kcal) 2379.81 ± 393.78 707.10 ± 63.66 *
Protein (g) 215.97 ± 38.55 222.60 ± 29.33
Carbohydrates (g) 43.75 ± 7.04 488.13 ± 52.36 *
Fat (g) 264.42 ± 43.75 78.57 ± 7.07 *
Protein (%) 24.65 ± 1.24 25.03 ± 0.91
Carbohydrates (%) 5.00 ± 0.00 55.00 ± 0.00 *
Fat (%) 68.00 ± 2.27 19.97 ± 0.91 *
All values are means ± SD. * significantly different from KD group (p < 0.05). KD, ketogenic diet group; WD,
western diet group.
2.4. Statistical Analysis
Data analysis was performed using GraphPad Prism software version 8.4.3 (Graph-
Pad Software, San Diego, CA, USA). Sample size was obtained assuming within subject
variability of 30% and a fixed power of 0.8, and an alpha risk of 0.05 for the main variables.
The analysis determined that at least eight participants per group were needed to achieve
the above parameters. Subjects were randomly allocated in one of the two groups using a
using computer generated software.
Results are presented as mean ± SD. After testing for normal distribution with the
Shapiro-Wilk W test, a two-way ANOVA for repeated measures was performed to compare
the two types of diet through a “time × diet” analysis. Whenever significant differences in
values were found, the post-hoc Bonferroni test was used to identify specific intragroup
differences. The p-value was set at 0.05.
3. Results
All the recruited subjects successfully completed the study.
Body composition analysis showed that the ketogenic regimen (KD) decreased body
weight by approximately 1% (from 86.39 ± 15.42 kg to 85.51 ± 13.62 kg), while the WD
determined an increase in weight of about 2% (from 89.04 ± 11.73 kg to 90.37 ± 9.91 kg).
Although these differences were not statistically significant (p > 0.05), they induced a
significant change in body composition (Figure 2). Fat mass significantly decreased only
in the KD group (KD: 9.86 ± 3.79 kg to 8.42 ± 2.41 kg, p < 0.05 vs. WD: 10.60 ± 3.92 kg
to 9.70 ± 2.53 kg) whereas, lean mass significantly increased only in the WD group (KD:
from 76.53 ± 12.13 kg to 77.09 ± 11.47 kg vs. WD: from 78.44 ± 8.31 kg to 80.67 ± 7.72 kg,
p < 0.05) presenting a significant time × diet interaction (p = 0.015). In terms of the fat
mass and lean mass distribution, it was observed that both groups reduced fat mass (KD:
−11.32 ± 7.88% vs. WD: −6.70 ± 10.02%), but the difference was statistically significant
only in KD group (p < 0.05). The decrease in the percentage of fat mass in the KD group
Nutrients 2021, 13, 374 6 of 14
was associated with a significant increase in lean mass (KD: + 1.63 ± 1.49%; p = 0.01 vs.
WD: +1.20 ± 1.62%; p = 0.05).
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Strength was increased in both study groups, both in the bench press test and in squat
test. There were no significant differences between study groups. As shown in Table 3,
the KD group improved their performance in bench press and squats by 4.13% and 3.62%;
while the WD group improved by 3.75% and 6.40%, respectively.
Table 3. Muscle strength and basal metabolism results.





p-ValuePre Post Pre Post
Bench press 1 RM (kg) 129.78 ± 20.98 134.44 ± 17.14 * 136.40 ± 11.27 141.40 ± 10.24 * ns 0.0009 ns
Squat 1 RM (kg) 181.33 ± 36.52 187.78 ± 37.41 * 176.10 ± 27.87 187.00 ± 26.96 * ns <0.00 1 ns
Basal metabolism (REE)
(Kcal/day) 2014.67 ± 324.04 2052.56 ± 317.99 2069.10 ± 229.32 2125.20 ± 206.08 * ns 0.0006 ns
Respiratory exchange
ratio (RER) 0.82 ± 0.01 0.79 ± 0.02 * 0.83 ± 0.01 0.83 ± 0.02 # 0.0022 0.0002 0.0001
All values are means ± SD. * significantly different from pre value (p < 0.05); # significantly different from KD group (p < 0.05). KD,
ketogenic diet group; WD, western diet group.
Analysis by indirect calorimetry (Table 3) showed a significant increase in REE only
in the WD group (WD: + 2.85 ± 1.78%; p < 0.05 vs. KD: + 1.99 ± 3.04%). RER revealed a
significant ti e × diet interaction (p < 0.0001) with a significant decrease only in the KD
group (−3.77 ± 1.86% p = 0.02), whilst in the WD group it remained unchanged.
Blood analyses revealed an improvement in the lipid profile only in the KD group
(Table 4). Indeed, total cholesterol significantly decreased in the KD group (KD:−3.51 ± 3.72%,
p < 0.05 vs. WD: −1.59 ± 3.51%) and the HDL component exhibited a significant time ×
diet interaction (p = 0.004), with an increase in the KD group (4.93 ± 3.53%, p < 0.05 vs.
WD: −1.07 ± 4.46%) and the difference between groups after eight weeks of intervention
was statistically different. Triglycerides also presented a significant time × diet interac-
tion (p < 0.001), in which lipids significantly decreased in the KD group (−17.44 ± 7.16%;
p < 0.0001) but not in the WD group (−1.59 ± 5.50%).
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Table 4. Blood parameters.





p-ValuePre Post Pre Post
Lipid profile
Total Cholesterol (mg/dL) 194.78 ± 8.88 187.89 ± 10.15 * 193.90 ± 18.18 190.60 ± 16.73 ns 0.0071 ns
HDL (mg/dL) 57.22 ± 3.33 60.00 ± 3.33 * 52.50 ± 6.11 51.80 ± 5.05 # 0.0072 ns 0.0039
LDL (mg/dL) 113.33 ± 8.88 108.00 ± 10.28 118.60 ± 20.64 116.20 ± 18.39 ns ns ns
TG (mg/dL) 121.00 ± 26.70 99.22 ± 19.72 * 114.70 ± 13.21 112.70 ± 13.06 ns <0.0001 0.0003
Transaminase
Aspartate transaminase (AST) (mg/dL) 38.78 ± 2.82 38.44 ± 2.54 39.10 ± 3.67 39.30 ± 4.11 ns ns ns
Alanine amino transferase (ALT) (mg/dL) 43.11 ± 6.51 38.56 ± 3.30 * 42.10 ± 6.59 44.80 ± 5.92 ns ns 0.0086
Anabolic Hormones
Testosterone total (nmol/L) 21.76 ± 5.33 19.32 ± 4.09 * 20.96 ± 5.13 21.27 ± 4.91 ns 0.0094 0.0016
IGF-1 (ng/mL) 213.33 ± 39.41 181.50 ± 25.93 * 222.40 ± 34.27 219.80 ± 23.42 # ns 0.0050 0.0124
All values are means ± SD. * significantly different from pre value (p < 0.05); # significantly different from KD group (p < 0.05). KD,
ketogenic diet group; WD, western diet group.
Similarly to what was seen for HDL cholesterol, glucose and insulin concentra-
tions also significantly decreased only in the KD group at the end of the eight weeks
of treatment (Figure 3). Plasma glucose levels were reduced from 98.67 ± 6.68 mg/dL
to 92.22 ± 4.76 mg/dL in the KD group (p < 0.001), and from 101.20 ± 3.12 mg/dL at
99.30 ± 4.76 mg/dL in the WD group. Insulinemia decreased from 2.40 ± 1.81 µU/mL
to 1.81 ± 0.31 µU/mL in the KD group (p < 0.0001) while in the WD group it went from
2.42 ± 0.39 µU/mL to 2.34 ± 0.33 µU/mL.
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Figure 3. Insulin sensitivity results. (A) plasma glucose concentration; (B) plasma insulin concentration. * significantly
different from pre-value (p < 0.05); # significantly different from KD group (p < 0.05); ¶ time × diet interaction (p < 0.05).
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Transaminase analysis (Table 4) showed no difference for aspartate transaminase
(AST), while a significant time × diet interaction (p < 0.01) was observed in alanine amino
transferase (ALT), whose concentrations decreased significantly only in the KD group
(p < 0.05) but not in the WD group.
As regards hormone levels, the trend already observed in other studies was confirmed,
in that anabolic hormones, such as testosterone and IGF-1 (Table 4), decreased in KD group.
A significant time × diet interaction was observed (p < 0.05), resulting in a significant de-
crease in the KD group (total testosterone −10.22 ± 6.95%, p < 0.001; IGF-1 −16.43 ± 8.52%,
p < 0.05) but not in the WD (testosterone total from −2.01 ± 5.45%; IGF-1 −0.18 ± 9.48%).
The analysis of inflammatory markers did not reveal any changes in IL-1 (KD: from
0.92 ± 0.14 pg/mL to 0.87 ± 0.10 pg/mL; WD: from 0.93 ± 0.10 pg/mL to 0.96 ± 0.08 pg/mL),
while a significant time × diet interaction (p < 0.05) emerged for IL-6 and TNF-α (Figure 4).
The IL-6 presented an opposite trend in the two groups; in fact it decreased in the KD group
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by 13.35% and increased in the WD group by 6.52%, resulting in a statistically significant
difference between the two groups at the end of the study protocol (KD: 1.17 ± 0.30 pg/mL
vs. WD: 1.55 ± 0.39 pg/mL; p < 0.05). TNF-α, on the other hand, remained almost
unchanged in the WD (from 5.33 ± 0.64 pg/mL to 5.30 ± 0.58 pg/mL), while it significantly
decreased in the KD group (from 5.12 ± 0.61 pg/mL to 4.69 ± 0.38 pg/mL; p < 0.01).
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Figure 4. Inflammatory markers and brain-derived neurotrophic factor (BDNF). (A) IL-6 concentration; (B) TNF- con-
centration; (C) BDNF concentration. * significantly different from pre-value (p < 0.05); # significantly different from KD 
group (p < 0.05); ¶ time × diet interaction (p < 0.05). KD, ketogenic diet group; WD, western diet group. 
Finally, BDNF concentrations (Figure 4) significantly increased only in the KD group 
(+25.84 ± 11.01%; p < 0.0001) at the end of the eight weeks of treatment (KD: 108.00 ± 15.68 
pg/mL vs. WD: 88.60 ± 10.62 pg/mL; p < 0.01). 
4. Discussion 
To our knowledge this is the first study analyzing the effects of a KD on bodybuild-
ers. Our findings confirm several preliminary data on the effects of KD diet on different 
power sports. KD induced a significant loss of fat mass without affecting muscle perfor-
mance. Interestingly, fat free mass was maintained throughout the two months of KD de-
spite a significant reduction in blood anabolic hormone concentrations. Moreover, blood 
lipids, glucose and inflammatory markers were improved in the KD group. 
While the effects of KD on fat mass are consistent in all studies evaluating body com-
position during KD regimens on athletes [13,20,40], the same was not confirmed for lean 
mass, with some authors showing a catabolic effect of KD on muscle [19,41–43], others 
showing no direct effects [13,44]. Only one study showed a higher increase in lean body 
mass that was measured after one week of carbohydrate recharge [45]. Muscle mass ac-
Figure 4. Inflammatory markers and brain-derived neurotrophic factor (BDNF). (A) IL-6 concentration; (B) TNF-α concen-
tration; (C) BDNF concentration. * significantly different from pre-value (p < 0.05); # significantly different from KD group
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Finally, BDNF concentrations (Figure 4) significantly increased only in the KD group
(+25.84 ± 11.01%; p < 0.0001) at the end of the eight weeks of treatment (KD: 108.00 ±
15.68 pg/mL vs. WD: 88.60 ± 10.62 pg/mL; p < 0.01).
4. Discussion
To our knowledge this is the first study analyzing the effects of a KD on bodybuilders.
Our findings confirm several preliminary data on the effects of KD diet on different power
sports. KD induced a significant loss of fat mass without affecting muscle performance.
Interestingly, fat free mass was maintained throughout the two months of KD despite a
significant reduction in blood anabolic hormone concentrations. Moreover, blood lipids,
glucose and inflammatory markers were improved in the KD group.
While the effects of KD on fat mass are consistent in all studies evaluating body
composition during KD regimens on athletes [13,20,40], the same was not confirmed for
lean mass, with some authors showing a catabolic effect of KD on muscle [19,41–43], others
showing no direct effects [13,44]. Only one study showed a higher increase in lean body
mass that was measured after one week of carbohydrate recharge [45]. Muscle mass accrual
is obtained under a chronic stimulation of muscle protein synthesis, which is governed
by hormonal (IGF-1, testosterone) and transcriptional regulatory pathway (Akt/mTOR).
During KD, the reduction in carbohydrates intake leads to a decrease in insulin levels [46].
Insulin is the main regulator of glucose uptake and is regulate by plasma glucose level;
as such, lower level of blood glucose caused by the reduction of carbohydrates ingestion,
inhibit β-cells insulin secretion [9]. Insulin is also a potent anabolic hormone [47], and
a reduction in insulin levels facilitates mobilization from fat stores due to its effects on
lipo-synthesis/lipolysis balance; on the other hand, it may inhibit muscle growth pathway.
On a transcriptional level, KD seems to be able to increase the phosphorylation of the
AMP-activated protein kinase (AMPK) [48], which has a well-known effect on Akt/mTOR
pathway’s inhibition [30]. In the present study we were not able to examine the effect of
KD on a molecular level, but we observed, as expected, a significant decrease in insulin
concentrations, which may play a role in body fat utilization [49]. We also observed an
unexpected decrease in testosterone concentration. Most of the studies conducted so far
showed a negligible effect of KD on testosterone [50,51], whilst our results showed a drop of
~11%, accompanied by a significant decrease in IGF-1 (~15%). Taken together, the anabolic
hormonal response seems to be blunted during the KD regimen, and this may explain
the attenuated hypertrophic response that was observed. However, in contrast with the
studies that showed a decrease in lean body mass during KD, we observed a preservation
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of FFM; this is most likely due to the effect of resistance training stimuli and also to the
maintenance of an high dietary protein level (2.5 g/BW) [13,14,17,52].
If a low carbohydrate intake has affected muscle gain, it did not alter muscle perfor-
mance. Strength and power athletes are recommended to maintain a higher carbohydrate
intake (3–8 g/kg) [53–55] to sustain the intramuscular glycogen stores and engage in greater
training volume. It has been observed that during KD regimen muscle glycogen stores
can decrease by ~40–50% [56,57]. In a recent study from Chappell et al. [23], the authors
observed that bodybuilders with better results during the competition season normally
consumed a greater amount of carbohydrates (5.1 g/kg) compared to non-placed athletes.
Recently, Vargas-Molina et al., while confirming the maintenance of lean body mass during
KD in strength trained women, found a decrease of strength in bench press and squat
exercises [20]. On the contrary, despite the above cited guidelines, we [13] and others [58]
observed similar improvement in strength expression after KD compared to normal diet
groups. Although further studies are required to better explore this aspect, the majority of
studies seem to indicate that KD does not impact muscle performance.
Variations in the basal metabolic rate and respiratory quotient parameters confirm
the ability of KD to lower the RER, indicating a shift towards lipid metabolism. Lower
RER value seems to predict a better ability to handle future body weight [59,60]; this could
be an advantage for bodybuilders, who normally undergo to repetitive cycle of bulking
and cutting during their carrier. Moreover, REE did not change in the KD group while
it was slightly increased in the WD group, suggesting that KD does not negatively affect
basal metabolism. The preservation of lean mass observed in the present study certainly
contributed to the control of basal metabolism [61]. Additionally, these results suggest that
an improvement in resting nutrient oxidation could be one of the main mechanisms by
which KD reduces body fat even though the energy intake was similar in the two groups.
There is still a debate about the mechanisms underlying the demonstrated greater effects
of KD on weight loss in ecological studies. There are some studies pointing out that that
the fat loss induced by a ketogenic diet relies only on calorie deficit [62] whilst others
suggested that KD induces an increase in REE [52,63]. No significant differences in energy
intake between groups were detected in our study. Thus, a possible explanation of the
greater fat loss in the KD may rely on increased (not measured in our study) spontaneous
physical activity during the daily normal activities as suggested by Hall et al. [64].
Bodybuilders’ training regimen, which unfortunately is sometimes accompanied with
the use of self-administrated steroids, may increase LDL concentration, and reduce HDL
levels, increasing the risk of cardiovascular diseases [65,66]. In this context, KD may
represent a useful tool to control lipid markers. The improvement in lipid profile with KD
is well documented in obese and overweight subjects [67,68], whilst the results are still
contradictory in athletes, probably due to the difference in the type of training (aerobic or
anaerobic activities) adopted in the study design [19,69]. We observed an improvement of
TGs, HDL and LDL cholesterol blood concentrations. KD can directly influence endogenous
cholesterol synthesis via the reduction of insulin production: insulin is indeed one of the
major activators of the HMGCoA reductase, the key enzyme of cholesterol biosynthesis.
The concomitant reduction in carbohydrates intake and increase in dietary cholesterol
(derived from fat intake) results in a consequent inhibition of endogenous cholesterol
production [70]. Moreover, during KD, dietary triglycerides are rapidly metabolized to
release glycerol, which can be used in the liver for energy purposes [71].
KD effect on insulin and glycemic control deserves mention. Several researches have
demonstrated that KD can reduce glucose and insulin concentration in obese, insulin
resistant individuals and diabetics [72–75]. This effect is not only related to a reduced
intake of glucose within the diet, but also to the improvement in insulin sensitivity [12]. In
the present study, despite the healthy status of the participants, KD induced a significant
drop in blood glucose which remained within normal levels. We also observed a significant
reduction in ALT levels. ALT is not only a hepatic enzyme (although non-specific) but it is
a critical enzyme for energy homeostasis. During fasting or sustained exercise, glucose can
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be synthetized from glucogenic amino acids, such as alanine and glutamate. Specifically,
ALT can convert alanine into pyruvate to generate glucose via gluconeogenesis [76]. In
obese and diabetic patient, elevated ALT activity has been associated with an impaired
insulin sensitivity [77,78] suggesting that ALT may play a pivotal role in the pathogenesis
of insulin resistance. The reduced ALT levels observed in the KD group may suggest that
the use of ketone bodies as an energy source is optimized to reduce the need for amino
acids for glucogenic purposes; on the other hand, these results also seem to confirm the
improvement in insulin sensitivity, and consequently a reduced risk of developing diabetes
or insulin resistance.
Another extremely interesting outcome is the inflammatory response. IL-1β remain
unaltered, whilst TNF-α and IL-6 decreased during KD. These cytokines are linked to
oxidative stress or inflammation; thus, their reduction could indicate an attenuation of
basal inflammatory status. Furthermore, TNF-α and IL-6 concentrations are generally
related to insulin levels; in fact, these cytokines play an important role in the pathogenesis
of insulin resistance [60–63]. Intense protocols of resistance training induce muscle damage,
which promote an acute inflammatory response and eventually generates oxygen free
radicals and lipid peroxidation [64,65]. If the acute rise in IL-6 could be related to training
and is indeed a fundamental factor in adapting to exercise stimuli, chronic elevated levels
of IL-6 can interact with the STAT3/TLR-4 pathway and decrease insulin sensitivity and
display an additional deleterious effect. KD seems to be a useful tool to modulate the
inflammatory response, reducing the basal level of proinflammatory cytokines.
Finally, we observed an increase in BDNF blood concentration during KD. BDNF is
a molecule of the neurotrophin family involved in trophism and neuronal plasticity, but
also in the energy modulation and glucose homeostasis of the central nervous system [79].
A reduction in this protein can be associated with situations of stress, depression, mood
disorders, cognitive aspects and other psychological problems [29,30]. An animal model of
depression presented reduced level of BDNF [80], and when administrated BDNF seems
to display antidepressant effect [81]. Some research has revealed that during weight loss
programs subjects may experience depression and negative feelings [28]. However, in
humans, KD has been shown to raise BDNF levels, probably via BHB regulation [82],
which was also associated with substantial improvement in cognitive function [83]. BHB
regulates BDNF expression in the mouse brain by a mechanism similar to the one induced
by exercise. Indeed, physical exercise increases BHB levels and BDNF expression in the
hippocampus [84]. BDNF expression is increased after an intraventricular infusion of
BHB [85]; thus, the increased level of blood BHB reached during a ketogenic diet [9,86]
may explain the increased BDNF in the KD group. We have already observed no negative
mood variations during KD [87] and an increased BDNF level may explain this observation;
moreover, a higher level of BDNF may improve cognition and memory, important factors
in athletes.
5. Limitations
One of the limitations of this study was the impossibility of standardizing training.
Participants were all experienced athletes with many years of training experience; all
performed from three to four sessions per week, but the volume and the intensity of the
workouts were decided by each individual. The competitive season always takes place
around the same time of the year, and the athletes were recruited and started the study in
the same period. Therefore, given that the study was conducted for all subjects at the same
time of the year (off-season), the training program was similar for participants and aimed
at improving muscle mass [21,88,89]. We should also point out that this research studied
expert bodybuilders, and thus not all the results may be generalized to other sports or the
general population.
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6. Conclusions
The results show that a KD diet may represent an adequate dietary approach for BB
athletes. Despite the lack of hypertrophic response in the KD group, muscle mass was
maintained, a phenomenon that often does not occur during low-calorie diets. Similarly,
although the time of year was not the one that athletes usually dedicate to training for fat
loss (“cutting”), KD proved to be a good strategy to reduce body fat.
KD also resulted in a decrease in inflammatory cytokines and the increase in BDNF,
suggesting that KD can be a valid tool for dealing with moments (such as that of “weightlift-
ing”) where stress management and maintenance of motivation are hard to handle. KD
is not a regime to be followed lightly and independently but requires the presence of a
professional; in these circumstances KD represents a fundamental tool in the nutritionist’s
baggage to face various conditions and needs, including those of sports.
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